|
1
|
Gündüz UR, Gunaldi M, Isiksacan N, Gündüz
S, Okuturlar Y and Kocoglu H: A new marker for breast cancer
diagnosis, human epididymis protein 4: A preliminary study. Mol
Clin Oncol. 5:355–360. 2016.PubMed/NCBI
|
|
2
|
Lu J, Steeg PS, Price JE, Krishnamurthy S,
Mani SA, Reuben J, Cristofanilli M, Dontu G, Bidaut L, Valero V, et
al: Breast cancer metastasis: Challenges and opportunities. Cancer
Res. 69:4951–4953. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang C, Liu K, Li T, Fang J, Ding Y, Sun
L, Tu T, Jiang X, Du S, Hu J, et al: miR-21: A gene of dual
regulation in breast cancer. Int J Oncol. 48:161–172. 2016.
|
|
4
|
Nogales-Cadenas R, Cai Y, Lin JR, Zhang Q,
Zhang W, Montagna C and Zhang ZD: MicroRNA expression and gene
regulation drive breast cancer progression and metastasis in PyMT
mice. Breast Cancer Res. 18:752016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Carthew RW and Sontheimer EJ: Origins and
mechanisms of miRNAs and siRNAs. Cell. 136:642–655. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Iorio MV, Ferracin M, Liu CG, Veronese A,
Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M,
et al: MicroRNA gene expression deregulation in human breast
cancer. Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kloosterman WP and Plasterk RH: The
diverse functions of microRNAs in animal development and disease.
Dev Cell. 11:441–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kou B, Gao Y, Du C, Shi Q, Xu S, Wang CQ,
Wang X, He D and Guo P: miR-145 inhibits invasion of bladder cancer
cells by targeting PAK1. Urol Oncol. 32:846–854. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qin J, Wang F, Jiang H, Xu J, Jiang Y and
Wang Z: MicroRNA-145 suppresses cell migration and invasion by
targeting paxillin in human colorectal cancer cells. Int J Clin Exp
Pathol. 8:1328–1340. 2015.PubMed/NCBI
|
|
10
|
Zhang Y and Lin Q: MicroRNA-145 inhibits
migration and invasion by down-regulating FSCN1 in lung cancer. Int
J Clin Exp Med. 8:8794–8802. 2015.PubMed/NCBI
|
|
11
|
Park SJ, Kim JG, Kim ND, Yang K, Shim JW
and Heo K: Estradiol, TGF-β1 and hypoxia promote breast cancer
stemness and EMT-mediated breast cancer migration. Oncol Lett.
11:1895–1902. 2016.PubMed/NCBI
|
|
12
|
Rakha EA, Reis-Filho JS, Baehner F, Dabbs
DJ, Decker T, Eusebi V, Fox SB, Ichihara S, Jacquemier J, Lakhani
SR, et al: Breast cancer prognostic classification in the molecular
era: The role of histological grade. Breast Cancer Res. 12:2072010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu K, Zhang C, Li T, Ding Y, Tu T, Zhou
F, Qi W, Chen H and Sun X: Let-7a inhibits growth and migration of
breast cancer cells by targeting HMGA1. Int J Oncol. 46:2526–2534.
2015.PubMed/NCBI
|
|
14
|
Lin S and Gregory RI: MicroRNA biogenesis
pathways in cancer. Nat Rev Cancer. 15:321–333. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death, and tumorigenesis. Br J Cancer.
94:776–780. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hiyoshi Y, Kamohara H, Karashima R, Sato
N, Imamura Y, Nagai Y, Yoshida N, Toyama E, Hayashi N, Watanabe M,
et al: MicroRNA-21 regulates the proliferation and invasion in
esophageal squamous cell carcinoma. Clin Cancer Res. 15:1915–1922.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ma L, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Vaknin-Dembinsky A, Charbit H, Brill L,
Abramsky O, Gur-Wahnon D, Ben-Dov IZ and Lavon I: Circulating
microRNAs as biomarkers for rituximab therapy, in neuromyelitis
optica (NMO). J Neuroinflammation. 13:1792016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li Y, Deng X, Zeng X and Peng X: The role
of miR-148a in cancer. J Cancer. 7:1233–1241. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li LZ, Zhang CZ, Liu LL, Yi C, Lu SX, Zhou
X, Zhang ZJ, Peng YH, Yang YZ and Yun JP: miR-720 inhibits tumor
invasion and migration in breast cancer by targeting TWIST1.
Carcinogenesis. 35:469–478. 2014. View Article : Google Scholar
|
|
21
|
Ni F, Gui Z, Guo Q, Hu Z, Wang X, Chen D
and Wang S: Downregulation of miR-362-5p inhibits proliferation,
migration and invasion of human breast cancer MCF7 cells. Oncol
Lett. 11:1155–1160. 2016.PubMed/NCBI
|
|
22
|
Cisneros-Soberanis F, Andonegui MA and
Herrera LA: miR-125b-1 is repressed by histone modifications in
breast cancer cell lines. Springerplus. 5:9592016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao L, Feng X, Song X, Zhou H, Zhao Y,
Cheng L and Jia L: miR-493-5p attenuates the invasiveness and
tumorigenicity in human breast cancer by targeting FUT4. Oncol Rep.
36:1007–1015. 2016.PubMed/NCBI
|
|
24
|
Li C, Xu N, Li YQ, Wang Y and Zhu ZT:
Inhibition of SW620 human colon cancer cells by upregulating
miRNA-145. World J Gastroenterol. 22:2771–2778. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sun Z, Zhang A, Jiang T, Du Z, Che C and
Wang F: MiR-145 suppressed human retinoblastoma cell proliferation
and invasion by targeting ADAM19. Int J Clin Exp Pathol.
8:14521–14527. 2015.
|
|
26
|
Jiang SB, He XJ, Xia YJ, Hu WJ, Luo JG,
Zhang J and Tao HQ: MicroRNA-145-5p inhibits gastric cancer
invasiveness through targeting N-cadherin and ZEB2 to suppress
epithelial-mesenchymal transition. Onco Targets Ther. 9:2305–2315.
2016.PubMed/NCBI
|
|
27
|
Li Y, Li Y, Liu J, Fan Y, Li X, Dong M,
Liu H and Chen J: Expression levels of microRNA-145 and
microRNA-10b are associated with metastasis in non-small cell lung
cancer. Cancer Biol Ther. 17:272–279. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dong R, Liu X, Zhang Q, Jiang Z, Li Y, Wei
Y, Li Y, Yang Q, Liu J, Wei JJ, et al: miR-145 inhibits tumor
growth and metastasis by targeting metadherin in high-grade serous
ovarian carcinoma. Oncotarget. 5:10816–10829. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen X, Dong C, Law PT, Chan MT, Su Z,
Wang S, Wu WK and Xu H: MicroRNA-145 targets TRIM2 and exerts
tumor-suppressing functions in epithelial ovarian cancer. Gynecol
Oncol. 139:513–519. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ding MJ, Su KE, Cui GZ, Yang WH, Chen L,
Yang M, Liu YQ and Dai DL: Association between transforming growth
factor-β1 expression and the clinical features of triple negative
breast cancer. Oncol Lett. 11:4040–4044. 2016.PubMed/NCBI
|
|
31
|
Zheng W: Genetic polymorphisms in the
transforming growth factor-beta signaling pathways and breast
cancer risk and survival. Methods Mol Biol. 472:265–277. 2009.
View Article : Google Scholar
|
|
32
|
Eder IE, Stenzl A, Hobisch A, Cronauer MV,
Bartsch G and Klocker H: Transforming growth factors-beta 1 and
beta 2 in serum and urine from patients with bladder carcinoma. J
Urol. 156:953–957. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tsushima H, Kawata S, Tamura S, Ito N,
Shirai Y, Kiso S, Imai Y, Shimomukai H, Nomura Y, Matsuda Y, et al:
High levels of transforming growth factor beta 1 in patients with
colorectal cancer: Association with disease progression.
Gastroenterology. 110:375–382. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Comerci JT Jr, Runowicz CD, Flanders KC,
De Victoria C, Fields AL, Kadish AS and Goldberg GL: Altered
expression of transforming growth factor-beta 1 in cervical
neoplasia as an early biomarker in carcinogenesis of the uterine
cervix. Cancer. 77:1107–1114. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Friess H, Yamanaka Y, Büchler M, Ebert M,
Beger HG, Gold LI and Korc M: Enhanced expression of transforming
growth factor beta isoforms in pancreatic cancer correlates with
decreased survival. Gastroenterology. 105:1846–1856. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sheen-Chen SM, Chen HS, Sheen CW, Eng HL
and Chen WJ: Serum levels of transforming growth factor beta1 in
patients with breast cancer. Arch Surg. 136:937–940. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen JY, Liu JH, Wu HD, Lin KH, Chang KC
and Liou YM: Transforming growth factor-β1 T869C gene polymorphism
is associated with acquired sick sinus syndrome via linking a
higher serum protein level. PLoS One. 11:e01586762016. View Article : Google Scholar
|
|
38
|
Kelly RJ and Morris JC: Transforming
growth factor-beta: A target for cancer therapy. J Immunotoxicol.
7:15–26. 2010. View Article : Google Scholar
|
|
39
|
Hornstein E, Mansfield JH, Yekta S, Hu JK,
Harfe BD, McManus MT, Baskerville S, Bartel DP and Tabin CJ: The
microRNA miR-196 acts upstream of Hoxb8 and Shh in limb
development. Nature. 438:671–674. 2005. View Article : Google Scholar : PubMed/NCBI
|
